Prolactin bioassay in schizophrenia before and after neuroleptics. 1992

C A Peabody, and M D Warner, and M Griffin, and N N Boutros, and I G Worsley, and H G Friesen
Department of Psychiatry, University of Texas Medical School, Houston.

Fifteen drug-free schizophrenic male inpatients and 14 normal control subjects were studied. The schizophrenic subjects had a significantly lower ratio of bioassay prolactin to radioimmunoassay prolactin before neuroleptic treatment than they did after treatment. The ratio was lower in the drug-free patients as compared with normal controls. These findings suggest that neuroleptic medications may alter the molecular forms of serum prolactin. The results also suggest that drug-free schizophrenic patients may have a different pattern of prolactin variants than normal subjects and that this difference could be secondary to a disordered tuberoinfundibular dopamine system or long-term effects of neuroleptic drugs.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005476 Fluphenazine A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE. Flufenazin,Fluphenazine Hydrochloride,Lyogen,Prolixin,Hydrochloride, Fluphenazine
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays

Related Publications

C A Peabody, and M D Warner, and M Griffin, and N N Boutros, and I G Worsley, and H G Friesen
January 1999, L'Encephale,
C A Peabody, and M D Warner, and M Griffin, and N N Boutros, and I G Worsley, and H G Friesen
March 1987, The American journal of psychiatry,
C A Peabody, and M D Warner, and M Griffin, and N N Boutros, and I G Worsley, and H G Friesen
May 1971, Nihon Naibunpi Gakkai zasshi,
C A Peabody, and M D Warner, and M Griffin, and N N Boutros, and I G Worsley, and H G Friesen
February 1990, Iowa medicine : journal of the Iowa Medical Society,
C A Peabody, and M D Warner, and M Griffin, and N N Boutros, and I G Worsley, and H G Friesen
January 1985, Advances in biochemical psychopharmacology,
C A Peabody, and M D Warner, and M Griffin, and N N Boutros, and I G Worsley, and H G Friesen
September 1973, Proceedings of the Royal Society of Medicine,
C A Peabody, and M D Warner, and M Griffin, and N N Boutros, and I G Worsley, and H G Friesen
October 1979, Biological psychiatry,
C A Peabody, and M D Warner, and M Griffin, and N N Boutros, and I G Worsley, and H G Friesen
June 1960, L'union medicale du Canada,
C A Peabody, and M D Warner, and M Griffin, and N N Boutros, and I G Worsley, and H G Friesen
March 1986, The Psychiatric clinics of North America,
C A Peabody, and M D Warner, and M Griffin, and N N Boutros, and I G Worsley, and H G Friesen
June 1983, Psychosomatics,
Copied contents to your clipboard!